MediPharm Labs Initiates Clinical Trial for Use of Cannabis to Treat Chronic Kidney Disease Patients and Improve Quality of Life
MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) is a global leader in […]
MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) is a global leader in […]
FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) announced that the U.S. Food […]
Goodness Growth Holdings, Inc., (CSE: GDNS; OTCQX: GDNSF) a cannabis company involved in cultivating, […]
Curaleaf Holdings (CSE: CURA) (OTCQX: CURLF), a leading American medical cannabis company, has announced […]
Khiron Life Sciences Corp., (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically-integrated, global operator […]
Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB:TBPMF), a leading company in cannabinoid-derived therapeutic research, announced today […]
Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, a leading […]
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF), a vertically-integrated, multi-state cannabis operator, and Goodness […]
Tilray Brands, Inc. (NASDAQ: TLRY) TSX: TLRY), a leading Canadian cannabis company, incorporated in […]
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), the cannabis company that has mainly focused […]
The Dank Investor is an industry leading cannabis financial services company providing breaking market news, analysis and leading insights about cannabis stocks for investors to grow their portfolios and minimize risk. Markets include NASDAQ, NYSE, OTC and other markets. Additionally, the company provides business services to companies in the cannabis sector through comprehensive corporate communication and marketing solutions.
The Dank Investment Community encompasses an engaged social media audience of over 50,000 who leverage our content to stay informed as investors.
We seek Safe Harbor.